---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

Amendment No. 18 to Schedule 13D

     The Schedule 13D, dated May 8, 1980, as amended, of Robert G. Wilmers, Elisabeth Roche Wilmers, Wilmers Company, L.L.C., West Ferry Foundation, R.I. REM Investments S.A., as the assignee of REM Foundation, Roche Foundation, St. Simon Charitable Foundation, Interlaken Foundation, Grantor Retained Annuity Trust No. 5, and Grantor Retained Annuity Trust No. 6 (collectively referred to as the “Reporting Persons”) is hereby amended as set forth below.

     The purpose of this Amendment No. 18 to the Schedule 13D is to report that Mr. Jorge G. Pereira, Hofin Anstalt (a corporation as to which Mr. Pereira holds sole voting and dispositive power), Alauda Investments Ltd. and Bikala Holdings Ltd. (wholly-owned subsidiaries of Hofin Anstalt), and Argali [BVI] Limited are no longer “Reporting Persons” on this Schedule 13D. In addition, this Amendment reflects the addition of the Interlaken Foundation as a “Reporting Person” and changes in the percentage of outstanding shares of M&T Bank Corporation (“M&T”) common stock, par value $.50 per share (“Shares”), beneficially owned by the Reporting Persons.

     This Amendment No. 18 to Schedule 13D should be read in conjunction with, and is qualified in its entirety by reference to the Schedule 13D and Amendments Nos. 1 through 17 thereto.

Item 2.      Identity and Background

      Item 2 of the Schedule 13D is amended as set forth below:

     Interlaken Foundation

     Interlaken Foundation, a not-for-profit, non-stock corporation organized under the laws of Delaware, was formed by Mr. Wilmers for the purpose of making charitable contributions. The principal address of Interlaken Foundation is c/o M&T Bank 350 Park Avenue, 6th Floor, New York, NY 10022. Mr. Wilmers is the president of the Interlaken Foundation.

     As reflected in the agreement included as Exhibit 99.1 hereto, Mr. Jorge G. Pereira, Hofin Anstalt, Alauda Investments Ltd., Bikala Holdings Ltd., and Argali [BVI] Limited are no longer “Reporting Persons” on this Schedule 13D. None of such persons, either individually or collectively, currently beneficially owns more than 5% of the Shares.

Item 5.      Interest in Securities of the Issuer

      Item 5 of the Schedule 13D is revised and amended and restated as set forth below:

     (a)-(b) The aggregate number and percentage of outstanding Shares beneficially owned by each Reporting Person are set forth below. Unless otherwise indicated, each

12

 

---

 

Reporting Person has sole voting and dispositive power with respect to the M&T Shares listed opposite his name.

     ¹ Based upon 120,106,490 Shares outstanding as of December 31, 2003. In calculating the beneficial ownership percentage of Mr. Wilmers and the aggregate percentage for all the Reporting Persons, Shares subject to options held by Mr. Wilmers which are currently exercisable or exercisable within 60 days from the date hereof are added to the Total Shares outstanding.

     ² Mr. Wilmers beneficially owns 5,499,526 Shares over which Mr. Wilmers has sole voting and dispositive power, such Shares representing approximately 4.6% of the Shares issued and outstanding. The number of Shares beneficially owned by Mr. Wilmers includes: (i) 3,422,173 Shares owned directly; (ii) 191,180 Shares owned by the West Ferry Foundation, a charitable trust formed by Mr. Wilmers, as to which Mr. Wilmers, as trustee, holds sole voting and dispositive power; (iii) 99,333 Shares owned by the Roche Foundation, a not-for-profit, non-stock corporation, as to which Mr. Wilmers, as director and president, holds sole voting and dispositive power; (iv) 400,000 Shares held by the Wilmers Company, L.L.C., as to which Mr. Wilmers, as sole member, holds sole voting and dispositive power; (v) 117,307 Shares owned by the St. Simon Foundation, a not-for-profit, non-stock corporation, as to which Mr. Wilmers, as a director and president, holds voting and dispositive power; (vi) 25,000 Shares held by the Interlaken Foundation, a not-for-profit, non-stock corporation, as to which Mr. Wilmers, as a director and president, holds voting and dispositive power; (vii) 214,540 Shares held by Grantor Retained Annuity Trust No. 5; (viii) 224,766 Shares held by Grantor Retained Annuity Trust No. 6; (ix) 38,228 Shares allocated under M&T’s Retirement Savings Plan and Trust (401(k) plan); and (x) 766,999 Shares subject to employee stock options granted to Mr. Wilmers which are currently exercisable within 60 days of the date hereof.

     (c) On May 23, 2003, the West Ferry Foundation transferred 9,000 of the Shares held by it by means of a gift. On May 29, 2003, Mr. Wilmers transferred, by means of a gift, 25,000 Shares each to the St. Simon Foundation and the Interlaken Foundation, respectively. On May 29, 2003, Mr. Wilmers also transferred 125 of the

13

 

---

 

Shares he held by means of a gift. No consideration was paid for such shares. Through September 30, 2003, Mr. Wilmers acquired an additional 648 Shares through his participation in M&T’s Retirement Savings Plan and Trust. On November 10, 2003, the Roche Foundation transferred 667 of the Shares it held by means of a gift. No consideration was paid for such shares. On January 16, 2004, Mr. Wilmers exercised employee stock options to purchase 200,000 Shares, and had 97,557 of such shares withheld to cover exercise costs and withholding taxes. On January 21, 2004, and January 22, 2004, Mr. Wilmers sold 100,000 and 2,443 Shares, respectively. The sales were open market, market price transactions. The Shares were sold at an average price of $91.54 per Share. The transactions were effected on the New York Stock Exchange. On January 21, 2004, Mr. Wilmers transferred 125 of the Shares he held by means of a gift. No consideration was paid for such shares.

     Other than the transactions set forth in this Item 5, routine allocations to Mr. Wilmers’ account under M&T’s Retirement Savings Plan and Trust, there were no transactions within the last 60 days by the Reporting Persons with respect to the Shares.

14

 

---

 

JOINT FILING AGREEMENT

     By signing this Amendment No. 18, each Reporting Person acknowledges and agrees that the Schedule 13D, as amended hereby, is filed on such Reporting Person’s behalf and agrees to such joint filing in accordance with Rule 13d-1(k) of the Securities and Exchange Commission.

SIGNATURES

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.

15

---

 

16